MedTrace Logo

Three-Chamber Bags Retrospective Study in Spain

NCT03284398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3723

Last updated 2021-01-29

Study results available
· View outcomes & findings →

Summary

The primary study objective is to assess the rates of blood stream infection (BSI) from the use of Three-Chamber Bags (e.g., SmofKabiven®, Kabiven®, others) compared to Hospital Compounded Bags (HCBs) in patients requiring parenteral nutrition in Spanish hospitals.

Conditions

  • Parenteral Nutrition
  • Blood Stream Infection

Sponsors & Collaborators

  • Fresenius Kabi

    lead INDUSTRY

Principal Investigators

  • John F Stover · Fresenius Kabi Deutschland GmbH, Borkenberg 14, 61440 Oberursel, Germany

  • Juan Carlos M González · Hospital Universitario 12 de Octubre, 28041 Madrid, Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284398 on ClinicalTrials.gov